Restricted accessResearch articleFirst published online 2023-09-12
Different Trajectories of Apathy and Depression Among Subjective Cognitive Impairment Individuals with or without Conversion to Dementia: Results from the Memento Cohort in France
Apathy and depression are two early behavioral symptoms in Alzheimer’s disease (AD) and related disorders that often occur prior to the onset of cognitive decline and memory disturbances. Both have been associated with an increased risk of conversion to dementia, with a distinct neuropathology.
Objective:
The assessment of the trajectories of apathy and depression and their independent impact on dementia conversion.
Methods:
Apathy and Depression were measured using the Neuropsychiatric Inventory for caregiver (NPI) and clinician (NPI-C), among the nondemented individuals reporting subjective cognitive decline (SCD) at baseline. They were followed up over a 60-month period. Some converted to dementia, according to the methodology carried out by the French Memento Cohort.
Results:
Among individuals with SCD (n = 2,323), the levels of apathy and depression were low and did not evolve significantly over the 60-month period, despite a trend in apathy increasing as of month 24. Regarding SCD individuals who converted to dementia within the 60-month period (n = 27), the prevalence of depression remained globally steady, while the levels of apathy increased over time.
Conclusion:
Apathy and depression have different trajectories among individuals with SCD and apathy alone is more likely—compared to depression—to be associated with conversion to dementia.
ApostolovaLG, CummingsJL (2008) Neuropsychiatric manifestations in mild cognitive impairment: A systematic review of the literature. Dement Geriatr Cogn Disord25, 115–126.
2.
IsmailZ, ElbayoumiH, FischerCE, HoganDB, MillikinCP, SchweizerT, MortbyME, SmithEE, PattenSB, FiestKM (2017) Prevalence of depression in patients with mild cognitive impairment: A systematic review and meta-analysis. JAMA Psychiatry74, 58–67.
3.
GaoY, HuangC, ZhaoK, MaL, QiuX, ZhangL, XiuY, ChenL, LuW, HuangC, TangY, XiaoQ (2013) Depression as a risk factor for dementia and mild cognitive impairment: A meta-analysis of longitudinal studies. Int J Geriatr Psychiatry28, 441–449.
4.
RobertP, LanctotKL, Aguera-OrtizL, AaltenP, BremondF, DefrancescoM, HanonC, DavidR, DuboisB, DujardinK, HusainM, KonigA, LevyR, MantuaV, MeulienD, MillerD, MoebiusHJ, RasmussenJ, RobertG, RuthirakuhanM, StellaF, YesavageJ, ZeghariR, ManeraV (2018) Is it time to revise the diagnostic criteria for apathy in brain disorders? The 2018 international consensus group. Eur Psychiatry54, 71–76.
5.
van DalenJW, van Wanrooij LL, Moll van CharanteEP, BrayneC, van GoolWA, RichardE (2018) Association of apathy with risk of incident dementia: A systematic review and meta-analysis. JAMA Psychiatry75, 1012–1021.
6.
ManeraV, FabreR, StellaF, LoureiroJC, Agüera-OrtizL, López-ÁlvarezJ, HanonC, HoertelN, AaltenP, RamakersI, ZeghariR, RobertP (2019) A survey on the prevalence of apathy inelderly people referred to specialized memory centers. Int JGeriatr Psychiatry34, 1369–1377.
7.
MurakamiT, HamaS, YamashitaH, OnodaK, KobayashiM, KanazawaJ, YamawakiS, KurisuK (2013) Neuroanatomic pathways associated with poststroke affective and apathetic depression. Am J Geriatr Psychiatry21, 840–847.
8.
EyreHA, SiddarthP, van DykK, St CyrN, BauneBT, BarrioJR, SmallGW, LavretskyH (2017) Neural correlates of apathy in late-life depression: A pilot [(18) F]FDDNP positron emission tomography study. Psychogeriatrics17, 186–193.
9.
PrangeS, MetereauE, MailletA, LhommeeE, KlingerH, PelissierP, IbarrolaD, HeckemannRA, CastriotoA, TremblayL, SgambatoV, BroussolleE, KrackP, ThoboisS (2019) Early limbic microstructural alterations in apathy and depression in de novo Parkinson’s disease. Mov Disord34, 1644–1654.
10.
IsmailZ, SmithEE, GedaY, SultzerD, BrodatyH, SmithG, Aguera-OrtizL, SweetR, MillerD, LyketsosCG, AreaINSPI (2016) Neuropsychiatric symptoms as early manifestations of emergent dementia: Provisional diagnostic criteria for mild behavioral impairment. Alzheimers Dement12, 195–202.
11.
LinY, ShanPY, JiangWJ, ShengC, MaL (2019) Subjective cognitive decline: Preclinical manifestation of Alzheimer’s disease. Neurol Sci40, 41–49.
12.
JessenF, AmariglioRE, van BoxtelM, BretelerM, CeccaldiM, ChetelatG, DuboisB, DufouilC, EllisKA, van der FlierWM, GlodzikL, van HartenAC, de LeonMJ, McHughP, MielkeMM, MolinuevoJL, MosconiL, OsorioRS, PerrotinA, PetersenRC, RabinLA, RamiL, ReisbergB, RentzDM, SachdevPS, de la SayetteV, SaykinAJ, ScheltensP, ShulmanMB, SlavinMJ, SperlingRA, StewartR, UspenskayaO, VellasB, VisserPJ, WagnerM, Subjective Cognitive Decline Initiative Working Group (2014) A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer’s disease. Alzheimers Dement10, 844–852.
13.
SheikhF, IsmailZ, MortbyME, BarberP, CieslakA, FischerK, GrangerR, HoganDB, MackieA, MaxwellCJ, MenonB, MuellerP, PatryD, PearsonD, QuickfallJ, SajobiT, TseE, WangM, SmithEE, PROMPT registry investigators (2018) Prevalence of mild behavioral impairment in mild cognitive impairment and subjective cognitive decline, and its association with caregiver burden. Int Psychogeriatr30, 233–244.
14.
MatthewsFE, ArthurA, BarnesLE, BondJ, JaggerC, RobinsonL, BrayneC (2013) A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: Results of the Cognitive Function and Ageing Study I and II. Lancet382, 1405–1412.
15.
RuthirakuhanM, HerrmannN, VieiraD, GallagherD, LanctotKL (2019) The roles of apathy and depression in predicting Alzheimer disease: A longitudinal analysis in older adults with mild cognitive impairment. Am J Geriatr Psychiatry27, 873–882.
16.
Vicini ChiloviB, ContiM, ZanettiM, MazzùI, RozziniL, PadovaniA (2009) Differential impact of apathy and depression inthe development of dementia in mild cognitive impairment patients. Dement Geriatr Cogn Disord27, 390–398.
17.
PalmerK, Di IulioF, VarsiAE, GianniW, SancesarioG, CaltagironeC, SpallettaG (2010) Neuropsychiatric predictors of progression from amnestic-mild cognitive impairment to Alzheimer’s disease: The role of depression and apathy. J Alzheimers Dis20, 175–183.
18.
KessingLV (2012) Depression and the risk for dementia. Curr Opin Psychiatry25, 457–461.
19.
ModregoPJ, FerrándezJ (2004) Depression in patients with mildcognitive impairment increases the risk of developing dementia ofAlzheimer type: A prospective cohort study. Arch Neurol61, 1290–1293.
20.
LeoutsakosJS, WiseEA, LyketsosCG, SmithGS (2019) Trajectories of neuropsychiatric symptoms over time in healthy volunteers and risk of MCI and dementia. Int J Geriatr Psychiatry34, 1865–1873.
21.
MartinE, VelayudhanL (2020) Neuropsychiatric symptoms in mild cognitive impairment: A literature review. Dement Geriatr Cogn Disord49, 146–155.
22.
DufouilC, DuboisB, VellasB, PasquierF, BlancF, HugonJ, HanonO, DartiguesJF, HarstonS, GabelleA, CeccaldiM, BeauchetO, Krolak-SalmonP, DavidR, RouaudO, GodefroyO, BelinC, RouchI, AugusteN, WallonD, BenetosA, ParienteJ, PaccalinM, MoreaudO, HommetC, SellalF, Boutoleau-BretonniereC, JalenquesI, GentricA, VandelP, AzouaniC, FillonL, FischerC, SavarieauH, OpertoG, BertinH, ChupinM, BouteloupV, HabertMO, ManginJF, ChêneG, MEMENTO cohort Study Group (2017) Cognitive and imaging markers in non-demented subjects attending a memory clinic: Study design and baseline findings of the MEMENTO cohort. Alzheimers Res Ther9, 67.
23.
MorrisJC (1993) The Clinical Dementia Rating (CDR): Current version and scoring rules. Neurology43, 2412–2414.
24.
CummingsJL, MegaM, GrayK, Rosenberg-ThompsonS, CarusiDA, GornbeinJ (1994) The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia. Neurology44, 2308–2314.
25.
de MedeirosK, RobertP, GauthierS, StellaF, PolitisA, LeoutsakosJ, TaraganoF, KremerJ, BrugnoloA, PorsteinssonAP, GedaYE, BrodatyH, GazdagG, CummingsJ, LyketsosC (2010) TheNeuropsychiatric Inventory-Clinician rating scale (NPI-C):Reliability and validity of a revised assessment of neuropsychiatricsymptoms in dementia. Int Psychogeriatr22, 984–994.
26.
AaltenP, de VugtME, JaspersN, JollesJ, VerheyFR (2005) The course of neuropsychiatric symptoms in dementia. Part I: Findings from the two-year longitudinal Maasbed study. Int J Geriatr Psychiatry20, 523–530.
27.
AaltenP, de VugtME, JaspersN, JollesJ, VerheyFR (2005) The course of neuropsychiatric symptoms in dementia. Part II: Relationships among behavioural sub-syndromes and the influence of clinical variables. Int J Geriatr Psychiatry20, 531–536.
28.
ZeitzerJM, DavidR, FriedmanL, MulinE, GarciaR, WangJ, YesavageJA, RobertPH, ShannonW (2013) Phenotyping apathy in individuals with Alzheimer disease using functional principal component analysis. Am J Geriatr Psychiatry21, 391–397.
29.
DavidR, MulinE, FriedmanL, Le DuffF, CygankiewiczE, DeschauxO, GarciaR, YesavageJA, RobertPH, ZeitzerJM (2012) Decreased daytime motor activity associated with apathy in Alzheimer disease: An actigraphic study. Am J Geriatr Psychiatry20, 806–814.
30.
McKhannG, DrachmanD, FolsteinM, KatzmanR, PriceD, StadlanEM (1984) Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology34, 939–944.
31.
RobertPH, BerrC, VolteauM, Bertogliati-FileauC, BenoitM, GuerinO, SarazinM, LegrainS, DuboisB (2008) Importance of lack of interest in patients with mild cognitive impairment. Am J Geriatr Psychiatry16, 770–776.
StarksteinSE, PetraccaG, ChemerinskiE, KremerJ (2001) Syndromic validity of apathy in Alzheimer’s disease. Am J Psychiatry158, 872–877.
34.
OlinJT, KatzIR, MeyersBS, SchneiderLS, LebowitzBD (2002) Provisional diagnostic criteria for depression of Alzheimer disease: Rationale and background. Am J Geriatr Psychiatry10, 129–141.
35.
KauferDI, CummingsJL, KetchelP, SmithV, MacMillanA, ShelleyT, LopezOL, DeKoskyST (2000) Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. J Neuropsychiatry Clin Neurosci12, 233–239.
36.
OlayaB, MonetaMV, MiretM, Ayuso-MateosJL, HaroJM (2019) Course of depression and cognitive decline at 3-year follow-up: The role of age of onset. Psychol Aging34, 475–485.
37.
DinizBS, ButtersMA, AlbertSM, DewMA, ReynoldsCF, 3rd (2013) Late-life depression and risk of vascular dementia and Alzheimer’s disease: Systematic review and meta-analysis of community-based cohort studies. Br J Psychiatry202, 329–335.
38.
GulpersB, RamakersI, HamelR, KöhlerS, Oude VoshaarR, VerheyF (2016) Anxiety as a predictor for cognitive decline and dementia: A systematic review and meta-analysis. Am J Geriatr Psychiatry24, 823–842.
39.
BensamounD, GuignardR, FurstAJ, DerreumauxA, ManeraV, DarcourtJ, BenoitM, RobertPH, DavidR (2016) Associations between neuropsychiatric symptoms and cerebral amyloid deposition in cognitively impaired elderly people. J Alzheimers Dis49, 387–398.
40.
LoTWB, KaramehWK, BarfettJJ, FornazzariLR, MunozDG, SchweizerTA, Fischer CE; Alzheimer’s Disease Neuroimaging Initiative (2020) Association between neuropsychiatric symptom trajectory and conversion to Alzheimer disease. Alzheimer Dis Assoc Disord34, 141–147.
41.
GonfrierS, AndrieuS, RenaudD, VellasB, RobertPH (2012) Course of neuropsychiatric symptoms during a 4-year follow up in the REAL-FR cohort. J Nutr Health Aging16, 134–137.
42.
DavidR, KoulibalyM, BenoitM, GarciaR, CaciH, DarcourtJ, RobertP (2008) Striatal dopamine transporter levels correlate with apathy in neurodegenerative diseases A SPECT study with partial volume effect correction. Clin Neurol Neurosurg110, 19–24.
43.
BogdanA, ManeraV, KoenigA, DavidR (2020) Pharmacologic approaches for the management of apathy in neurodegenerative disorders. Front Pharmacol10, 1581.
44.
BenoitM, RobertPH (2011) Imaging correlates of apathy and depression in Parkinson’s disease. J Neurol Sci310, 58–60.
45.
KimJW, LeeDY, ChooIH, SeoEH, KimSG, ParkSY, WooJI (2011) Microstructural alteration of the anterior cingulum is associated with apathy in Alzheimer disease. Am J Geriatr Psychiatry19, 644–653.
46.
DelrieuJ, DesmidtT, CamusV, SourdetS, Boutoleau-BretonnièreC, MullinE, VellasB, PayouxP, LebouvierT (2015) Apathy as a feature of prodromal Alzheimer’s disease: An FDG-PET ADNI study. Int J Geriatr Psychiatry30, 470–477.
BrendelM, SauerbeckJ, GrevenS, KotzS, ScheiweinF, BlautzikJ, DelkerA, PogarellO, IshiiK, BartensteinP, RomingerA (2018) Serotonin selective reuptake inhibitor treatment improves cognition and grey matter atrophy but not amyloid burden during two-year follow-up in mild cognitive impairment and Alzheimer’s disease patients with depressive symptoms. J Alzheimers Dis65, 793–806.
49.
BartelsC, WagnerM, WolfsgruberS, EhrenreichH, SchneiderA (2018) Impact of SSRI therapy on risk of conversion from mild cognitive impairment to Alzheimer’s dementia in individuals with previous depression. Am J Psychiatry175, 232–241.
50.
CaraciF, SpampinatoSF, MorgeseMG, TasceddaF, SalluzzoMG, GiambirtoneMC, CarusoG, MunafòA, TorrisiSA, LeggioGM, TrabaceL, NicolettiF, DragoF, SortinoMA, CopaniA (2018) Neurobiological links between depression and AD: The role of TGF-β1 signaling as a new pharmacological target. Pharmacol Res130, 374–384.
51.
WalkerFR (2013) A critical review of the mechanism of action for the selective serotonin reuptake inhibitors: Do these drugs possess anti-inflammatory properties and how relevant is this in the treatment of depression?Neuropharmacology67, 304–317.
52.
GoodwinGM, PriceJ, De BodinatC, LaredoJ (2017) Emotional blunting with antidepressant treatments: A survey among depressed patients. J Affect Disord221, 31–35.
53.
VelloneD, GhahremaniM, GoodarziZ, ForkertND, SmithEE, IsmailZ (2022) Apathy and APOE in mild behavioral impairment, and risk for incident dementia. Alzheimers Dement (N Y)8, e12370.
54.
EikelboomWS, PanM, OssenkoppeleR, CoesmansM, GatchelJR, IsmailZ, LanctôtKL, FischerCE, MortbyME, van den BergE, PapmaJM (2022) Sex differences in neuropsychiatric symptoms in Alzheimer’s disease dementia: A meta-analysis. Alzheimers Res Ther14, 48.
55.
CaoQ, TanCC, XuW, HuH, CaoXP, DongQ, TanL, YuJT (2020) The prevalence of dementia: A systematic review and meta-analysis. J Alzheimers Dis73, 1157–1166.
56.
VandenbrouckeJP, vonElm E, AltmanDG, GøtzschePC, MulrowCD, PocockSJ, PooleC, SchlesselmanJJ, EggerM; STROBE Initiative (2007) Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and elaboration. Epidemiology18, 805–835.
